The state of Georgia currently has 2 active clinical trials seeking participants for Hepatitis C research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
Recruiting
Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. This study will evaluate how safe and effective glecaprevir/pibrentasvir (GLE/PIB) is in adult and adolescent participants with acute HCV infection. GLE/PIB is an approved drug for the treatment of chronic HCV. Around 283 participants at least 12 years of age with acute HCV Infection will be enrolled in approximately 70 sites worldwide. Participants... Read More
Gender:
All
Ages:
12 years and above
Trial Updated:
02/08/2024
Locations: Emory Midtown Infectious Disease Clinic /ID# 229927, Atlanta, Georgia
Conditions: Hepatitis C Virus (HCV)
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Recruiting
Clinical interventions to reduce the risk of vertical transmission of hepatitis C virus (HCV) infection from mother to infant are highly limited. Direct-acting antiviral (DAA) medications have demonstrated excellent safety and efficacy in non-pregnant individuals, but there is a lack of data regarding the safety of these medications in pregnant women and the effectiveness of these medications in reducing mother-to-child transmission. Therefore, although HCV screening during pregnancy is now reco... Read More
Gender:
All
Ages:
All
Trial Updated:
05/06/2022
Locations: The Taskforce for Global Health, Atlanta, Georgia
Conditions: Hepatitis C